Standard BioTools
LAB
LAB
84 hedge funds and large institutions have $217M invested in Standard BioTools in 2018 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 38 increasing their positions, 18 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
0.42% more ownership
Funds ownership: 95.01% → 95.42% (+0.42%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% less capital invested
Capital invested by funds: $217M → $217M (-$852K)
Holders
84
Holding in Top 10
1
Calls
$238K
Puts
$227K
Top Buyers
| 1 | +$3.2M | |
| 2 | +$2.18M | |
| 3 | +$904K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$873K |
| 5 |
Renaissance Technologies
New York
|
+$858K |
Top Sellers
| 1 | -$6.78M | |
| 2 | -$1.31M | |
| 3 | -$1.3M | |
| 4 |
SAM
Silverback Asset Management
Chapel Hill,
North Carolina
|
-$846K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$707K |